Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Teeft.i » - entrée « Relapse »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Rekombinanter < Relapse < Relapse rate  Facettes :

List of bibliographic references indexed by Relapse

Number of relevant bibliographic references: 70.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
002528 (2014) Ann-Sophie Lauenstein [Allemagne] ; Mark Stettner [Allemagne] ; Bernd C. Kieseier [Allemagne] ; Eckart Lensch [Allemagne]Treating neuromyelitis optica with the interleukin-6 receptor antagonist tocilizumab
002873 (2013) Sarah Louise Mackie [Royaume-Uni] ; Colin Thomas Pease [Royaume-Uni]Diagnosis and management of giant cell arteritis and polymyalgia rheumatica: challenges, controversies and practical tips
002905 (2013) The 24th Annual Meeting of Japanese Society of Neuroimmunology (JSNI)
002A46 (2013) S. Das [Royaume-Uni] ; S. Horton [Royaume-Uni] ; E. Vital ; D. Bryer [Royaume-Uni] ; P. Emery [Royaume-Uni] ; M. Buch [Royaume-Uni]THU0089 Response to abatacept and tocilizumab in patients who had failed rituximab– initial single centre experience
002A47 (2013) G. Arumugakani [Royaume-Uni] ; A. Rawstron ; R. Tooze [Royaume-Uni] ; A. Cherukuri ; A. Varghese ; E. Vital [Royaume-Uni] ; P. Emery [Royaume-Uni] ; D. Mcgonagle [Royaume-Uni]THU0088 Abnormal memory B-cell reconstitution following anti-CD20 therapy for autoimmune diseases predicts clinical relapse
002A75 (2013) C. Salvarani [Italie]SP0077 Vasculitis: Year in Review
002A76 (2013) R. F. Van Vollenhoven [Suède]SP0076 What is New in SLE and APS
002A77 (2013) B. Svanberg [Suède]SP0075 Swedish Case Study to Empower People with RMDs
002B39 (2013) Y. Mochida ; K. Ishii ; K. Harigane ; Y. Yamada ; N. Mitsugi ; T. Saito [Japon]SAT0156 Histological and immunohistochemical analyses of surgically resected synovial tissues in patients with rheumatoid arthritis treated with/without biological agents
002C08 (2013) T. Krams ; A. Ruyssen-Wtrand [France] ; D. Nigon ; B. Fautrel ; F. Berenbaum [France] ; A. Cantagrel ; A. Constantin [France]SAT0022 In Rheumatoid Arthritis, Younger Age at Onset is Associated with a Higher Rate of Remission at 1 Year: Results from a French Cohort of Early Arthritis Patients (Espoir Cohort)
002C09 (2013) T. Iwamoto ; K. Ikeda ; J. Hosokawa ; M. Yamagata ; S. Tanaka ; Y. Sanayama ; D. Nakagomi ; A. Okubo ; K. Takahashi ; K. Hirose ; M. Sueishi [Japon] ; H. NakajimaSAT0021 Both Gray-Scale Synovial Hypertrophy and Synovial Power Doppler Signals on a Comprehensive Ultrasound Scan are the Predictive Factors of Relapse After Discontinuation of Biological Agents in Patients with Rheumatoid Arthritis
002C10 (2013) S. M. Goodman ; B. Johnson ; W.-T. Huang [États-Unis] ; M. P. Figgie [États-Unis] ; M. Alexiades [États-Unis] ; L. A. MandlSAT0020 Rheumatoid Arthritis (RA) Patients Have Similar Excellent Outcomes After Total Knee Replacement Compared with Osteoarthritis (OA) Patients
002C14 (2013) Akiyuki Uzawa [Japon] ; Masahiro Mori [Japon] ; Satoshi Kuwabara [Japon]Role of interleukin‐6 in the pathogenesis of neuromyelitis optica
002C19 (2013) Toby Helliwell ; Samantha Hider ; Christian MallenRecommended management of polymyalgia rheumatica
002C36 (2013) OS42: Interstitial Lung Disease 6
002C37 (2013) OS41: Tuberculosis 5
002C38 (2013) OS40: COPD 4
002C39 (2013) OS39: Clinical Allergy & Immunology
002C40 (2013) OS38: Interstitial Lung Disease 5
002C41 (2013) OS37: Tuberculosis 4
002C42 (2013) OS36: COPD 3

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i -k "Relapse" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i  \
                -Sk "Relapse" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Relapse
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021